Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insect sting anaphylaxis.

David B K Golden1

  • 1Johns Hopkins University, 733 North Broadway, Baltimore, MD 21205, USA. dgolden1@jhmi.edu

Immunology and Allergy Clinics of North America
|May 12, 2007
PubMed
Summary
This summary is machine-generated.

Anaphylaxis from insect stings can be fatal, even in first-time reactions. Venom immunotherapy is highly effective (75-98%) in preventing severe sting reactions and is often discontinued after 5 years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Venom Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same author

Guidelines and shared decision-making for disruptive innovations in allergy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026
Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026
Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026
Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026
See all related articles

Area of Science:

  • Allergy and Immunology
  • Toxicology

Background:

  • Anaphylaxis to insect stings affects 3% of adults and can be fatal.
  • While large local reactions are common, systemic reactions pose a significant risk, varying by age and prior reaction severity.

Purpose of the Study:

  • To review the diagnosis, risk factors, and effective management of insect sting anaphylaxis.
  • To highlight the efficacy of venom immunotherapy in preventing future severe reactions.

Main Methods:

  • Diagnostic accuracy of venom skin tests and radioallergosorbent test (RAST) were evaluated.
  • Historical data on previous sting reactions and patient history were emphasized for risk assessment.
  • Efficacy rates of venom immunotherapy were analyzed.

Main Results:

Related Experiment Videos

  • Venom skin tests and RAST are key diagnostic tools, though sensitivity levels do not reliably predict reaction severity.
  • Patient history is crucial as 25% of adults show venom sensitization.
  • Venom immunotherapy demonstrates high effectiveness (75-98%) in preventing anaphylaxis.

Conclusions:

  • Effective diagnosis and risk assessment are vital for managing insect sting allergies.
  • Venom immunotherapy offers a highly successful preventative strategy for sting anaphylaxis.
  • Long-term treatment is often unnecessary, with most patients discontinuing therapy after 5 years with minimal risk.